Tools

LEADER 03469nam 2200589 i 4500

001 on1528822290;

005 20250724063745.0;

006 m o d f ;

007 cr mn|||||||||;

008 250724s2025 dcua ob f000 0 eng c;

024 8 z| 56-403q| (GPO jacket number);

035 a| (Sirsi) o1528822290;

035 a| (OCoLC)1528822290;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1037-D (online);

086 0 a| Y 4.G 74/9:S.HRG.118-376;

245 10 a| Risky research :b| oversight of U.S. taxpayer funded high risk virus research : hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eighteenth Congress, second session, July 11, 2024.;

246 3 a| Oversight of United States taxpayer funded high risk virus research;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2025.;

300 a| 1 online resource (iv, 942 pages) :b| color illustrations.;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| S. hrg. ;v| 118-376;

500 a| Redacted text.;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Gerald W. Parker, DVM, Ph.D., Associate Dean for Global One Health, College of Veterinary Medicine Director, Biosecurity and Pandemic Preparedness Policy Program Scowcroft Institute of International Affairs, Texas A&M University; Carrie D. Wolinetz, Ph.D., Senior Principal and Chair Health & Bioscience Innovation Practice, Lewis-Burke Associates, LLC; Robert R. Redfield, M.D., Former Director (2018-2021) Centers for Disease Control and Prevention, U.S. Department of Health, and Human Services; Kevin M. Esvelt, Ph.D., Associate Professor MIT Media Lab, Massachusetts Institute of Technology.;

518 a| Date of hearing: 2024-07-11.;

588 a| Description based on online resource, PDF version; title from title page (GovInfo, viewed July 23, 2025).;

650 0 a| Virologyx| Researchz| United States.=| ^A77071;

650 0 a| Pathogenic virusesx| Security measuresz| United States.=| ^A1273032;

650 0 a| Pathogenic virusesx| Government policyz| United States.=| ^A1273032;

650 7 a| Armed Forces and National Security.2| cgpa;

650 7 a| Government Operations and Politics.2| cgpa;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs.t| Risky researchw| (OCoLC)1528822255;

810 1 a| United States.b| Congress.b| Senate.t| S. hrg. ;v| 118-376.=| ^A500722;

856 40 u| https://purl.fdlp.gov/GPO/gpo2471097| 0;

856 4 z| Address at time of PURL creationu| https://www.govinfo.gov/content/pkg/CHRG-118shrg56403/pdf/CHRG-118shrg56403.pdf;

949 a| Click on web addressw| asish| joyner94o| jjlm;

994 a| C0b| GPO;

922 a| BIBCONEWb| 20250724;

922 a| GOVINFOHRG;

955 a| bc47 20250724b| 20250724;

596 a| 1;

998 a| 6610738;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6610738-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 8/22/2025x| EDOCUMENTz| JERESOURCEo| .STAFF. jjlm;

Risky research : oversight of U.S. taxpayer funded high risk virus research : hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eighteenth Congress, second session, July 11, 2024.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2025.
Description	1 online resource (iv, 942 pages) : color illustrations.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo247109
Supplemental Content	Address at time of PURL creation
Subjects	Virology--Research. --United States. Pathogenic viruses--Security measures. --United States. Pathogenic viruses--Government policy. --United States.

Variant title	Oversight of United States taxpayer funded high risk virus research
Series	S. hrg. ; 118-376 United States. Congress. Senate. S. hrg. ; 118-376. ^A500722
General note	Redacted text.
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Gerald W. Parker, DVM, Ph.D., Associate Dean for Global One Health, College of Veterinary Medicine Director, Biosecurity and Pandemic Preparedness Policy Program Scowcroft Institute of International Affairs, Texas A&M University; Carrie D. Wolinetz, Ph.D., Senior Principal and Chair Health & Bioscience Innovation Practice, Lewis-Burke Associates, LLC; Robert R. Redfield, M.D., Former Director (2018-2021) Centers for Disease Control and Prevention, U.S. Department of Health, and Human Services; Kevin M. Esvelt, Ph.D., Associate Professor MIT Media Lab, Massachusetts Institute of Technology.
Date/time/place of a event note	Date of hearing: 2024-07-11.
Source of description	Description based on online resource, PDF version; title from title page (GovInfo, viewed July 23, 2025).
Issued in other form	Print version: United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs. Risky research
Genre/form	Legislative hearings.
Standard identifier#	56-403 (GPO jacket number)
GPO item number	1037-D (online)
Govt. docs number	Y 4.G 74/9:S.HRG.118-376

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Online Content https://purl.fdlp.gov/GPO/gpo247109 Address at time of PURL creation	✔ Available

Risky research : oversight of U.S. taxpayer funded high risk virus research : hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eighteenth Congress, second session, July 11, 2024.

Click here for more information about this title

Availability